Although LAIR-2 protein had been detected in the urine of pregnant women [37], the genome-wide microarray analysis of CVS specimens was the first to identify the gene being expressed at the maternal-fetal interface in the placenta, where it was down-regulated in preeclampsia cases [7,11]. The gene discussed is LAIR2; the disease is preeclampsia.